The new products and growth sectors driving America’s long-term winners
Felix Wintle, manager of the VT Tyndall North American Fund, highlights three favourite US stocks where he'd put his money
Our investment process focuses on companies that are growing revenue, margins and earnings. When you find these three factors accelerating at the same time, there is a good chance you have a stock that’s going to perform well. We often find that companies with these characteristics are at the beginning of a new product cycle, and much of our stock analysis is concentrated on finding those companies.
We marry our fundamental work with macroeconomic analysis, which helps us identify where we are in the business cycle. This informs our risk appetite: aggressive in bull markets, defensive in bear markets. Finally, we use technical analysis to time our buys and sells.
Our style is active, and we like to find stocks exhibiting strong share price momentum, showing that the market validates our fundamental views. In constructing our portfolio, we apply a split approach – core stock selection based on finding long-term thematic winners, and tactical selection driven by the outlook for growth and inflation.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The resulting portfolio tends to vary significantly from both the index and our peer group. We believe that the following three stocks boast considerable upside potential.
Two top investment themes
Palantir (Nasdaq: PLTR) is at the centre of two of the biggest investment themes of today, namely defence and AI. It is a software developer embedded with organisations such as the CIA and the US military, enabling them to interpret and use the huge amounts of data they receive on a daily basis.
Palantir also has commercial applications and helps companies optimise their supply chains and other operational functions. The company is unique in that it doesn’t have any true competitors in terms of the product suite it provides. It is growing revenue at an annual pace of 55% and looks set to continue its strong performance.
Axon Enterprises (Nasdaq: AXON) is the company formerly known as Taser, and it still makes the iconic Taser product. Its mission is to dramatically reduce the number of deaths by firearms, and it has done that over the years as its non-lethal alternative has gained traction globally. It also has a bodycam product, which is where the real potential lies. The bodycam videos the arrests of suspects, and then Axon’s AI software takes the footage and writes up reports for police officers. This saves an average of four hours of police time a day and is one of the few real-world applications of AI today. Axon’s penetration of global markets is still in the single digits, and we believe it can continue its 27% top-line growth.
More bang for the buck
We believe that Dollar General (NYSE: DG) is in the early stages of a big turnaround. The main reason for this is that one of its competitors in the dollar-store sector, Family Dollar, is closing stores at a rapid rate, and in doing so, it is donating market share to Dollar General. Its last earnings call gave this thesis a boost – the company reported accelerating revenue and margins, and the stock jumped 16%.
Concerns over tariffs and household spending have been priced into this stock, in our view, and with the company trading at 0.4 times sales, it is cheap and primed for a rerating.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Felix has managed the VT Tyndall North American Fund since July 2017 when he joined Tyndall Investment Management. He began his career in September 1999 at City Financial Asset Management, becoming manager of the CF Biotech Fund in 2003. In 2004, the firm was acquired by Neptune Investment Management and he took over management of the Neptune US Opportunities Fund in August 2005, which he ran until May 2016.
-
Taxpayers urged to fight automated HMRC penalties as 20,000 win on appealHMRC loses more than 60% of cases when taxpayers appeal an automated penalty it has imposed, new figures show.
-
More than five million taxpayers overpay with wrong tax codes – how to check yours is rightHMRC overcharged taxpayers £3.5 billion in income tax the latest data shows, with tax coding errors largely to blame. Accountants say it is “essential” people check their tax codes to avoid being hit with higher bills.
-
Profit from pest control with Rentokil InitialRentokil Initial is set for global expansion and offers strong sales growth
-
Three funds to buy for capital growth and global incomeOpinion Three investment trusts with potential for capital growth, selected by Adam Norris, co-portfolio manager of the CT Global Managed Portfolio Trust
-
PayPoint: a promising stock for income-seekersPayPoint, a household name across Britain, is moving away from its traditional roots toward a digital future. Investors after a steady income should buy in
-
Vaccines inject billions into Big Pharma – how to profit from the sectorThe vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Here's what it means for investors
-
Stock markets have a mountain to climb: opt for resilience, growth and valueOpinion Julian Wheeler, partner and US equity specialist, Shard Capital, highlights three US stocks where he would put his money
-
Goodwin: A superlative British manufacturer to buy nowVeteran engineering group Goodwin has created a new profit engine. But following its tremendous run, can investors still afford the shares?
-
A change in leadership: Is US stock market exceptionalism over?US stocks trailed the rest of the world in 2025. Is this a sign that a long-overdue shift is underway?
-
Profit from document shredding with RestoreRestore operates in a niche, but essential market. The business has exciting potential over the coming years, says Rupert Hargreaves
